Document Detail

Pure Apocrine Nevus: Immunohistochemical Study of a New Case and Literature Review.
MedLine Citation:
PMID:  21212656     Owner:  NLM     Status:  Publisher    
Apocrine nevi are benign adnexal cutaneous hamartomas characterized by localized hyperplasia of mature apocrine sweat glands (ASG). Although ASG proliferation can be found in a number of acquired or congenital adnexal skin tumors, pure apocrine nevi are exceedingly rare. We present herein a new typical case of this tumor that was studied immunohistochemically, and review the relevant literature in order to delineate its clinicopathological features.
J Kanitakis; K Kyamidis; A Toussinas; G Tsoïtis
Related Documents :
22067016 - Terminal hematuria associated with oral isotretinoin treatment in a patient with acne v...
18024066 - Diethylene glycol: widely used solvent presents serious poisoning potential.
9347666 - A study of epidemiology, risk factors and preventive measures against snake bites.
16672686 - Chronic addiction to dextromethorphan cough syrup: a case report.
9013346 - Brucellosis and the gastrointestinal tract. the odd couple.
24684196 - April 2014 book reviews.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-05
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  -     ISSN:  1421-9832     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 S. Karger AG, Basel.
Department of Dermatology and Laboratory of Dermatopathology, Edouard Herriot Hospital, Lyon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Large Umbilical Artery Aneurysm with a Live Healthy Baby Delivered at 31 Weeks.
Next Document:  Aberrant Methylation of Death-Associated Protein Kinase 1 CpG Islands in Myelodysplastic Syndromes.